Maj. Gen (Retd) Rehmat Khan, President of Al-Shifa Trust, highlighted the importance of early diagnosis and regular monitoring during the inauguration. He noted that timely intervention can significantly reduce the risks associated with thyroid eye disease, which affects an estimated 3-5% of Pakistan’s population, predominantly women.
A recent study in Lahore indicated that 12-13% of the population suffers from thyroid dysfunction. The absence of adequate public care often forces patients into expensive private treatment, leaving many untreated.
Dr. Tayyab Afghani, Head of the Orbit and Oculoplastic Department at the hospital, explained that treatment costs are a barrier, with surgeries costing up to Rs 2 lakhs and medications ranging from Rs 5,000 to 7,000. The latest medicine, available only in the US, costs up to $17,000, making it inaccessible locally.
Al-Shifa Trust plans to expand access through telemedicine services and mobile clinics to reach underserved areas. These initiatives aim to improve diagnosis rates and enhance treatment quality. Public health campaigns will also be launched to raise awareness about smoking as a critical risk factor and the importance of seeking specialist care.
Statistics reveal that Thyroid Eye Disease affects 5 to 16 new people per 100,000 annually, with women being significantly more susceptible. The condition primarily affects adults aged 35 to 60, with 20% of cases exhibiting moderate to severe symptoms.